Rapid immunoassay analyzers market to reach $2.08B by 2030

The Business Research Company says the rapid immunoassay analyzers market will grow from $1.23 billion in 2025 to $1.36 billion in 2026, then reach $2.08 billion by 2030. The forecast points to rising demand for faster diagnostics, home testing, and automated lab systems across North America, Asia-Pacific and other regions.

Why it matters: - Rapid immunoassay analyzers are becoming more important as healthcare providers push for faster and more precise diagnosis. - The market is tied to early disease detection, ongoing patient monitoring and point-of-care testing. - Rising disease burden and broader preventive screening needs are expanding demand for these systems.

What happened: - The Business Research Company published its "Rapid Immunoassay Analyzers Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035" on July 7, 2026. - The report puts the market at $1.23 billion in 2025 and $1.36 billion in 2026. - The report forecasts the market will reach $2.08 billion by 2030. - The company says the market is growing at a 10.8% CAGR from 2025 to 2026 and is expected to grow at an 11.1% CAGR through 2030. - A free sample is available here. - The full report is available here.

The details: - Rapid immunoassay analyzers detect and measure biological markers through antigen-antibody interactions. - The systems use fluorescence, chemiluminescence or lateral flow assay technologies. - The devices are designed to deliver results within minutes. - The report cites growth drivers including infectious and chronic disease prevalence, demand for rapid diagnosis, point-of-care testing adoption, diagnostic lab expansion and preventive health awareness. - Future growth is linked to next-generation biomarker detection, decentralized diagnostics, home-based testing, automated laboratory setups and connected digital health monitoring. - Key trends include rapid point-of-care tests, portable and handheld analyzers, multiplex testing for infectious diseases, high-throughput automated immunoassay instruments and faster turnaround times with accurate clinical results. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

Between the lines: - The forecast suggests rapid immunoassay analyzers are moving from a niche lab tool toward a broader role in decentralized and home-based care. - The emphasis on portable, multiplex and connected systems signals a market where speed and workflow efficiency matter as much as test accuracy. - The report's regional split points to mature demand in North America and faster adoption potential in Asia-Pacific.

What's next: - The market is expected to keep expanding as healthcare systems adopt more automated and distributed diagnostic workflows. - Product development will likely center on faster turnaround, portability and digital integration. - Broader use of connected testing platforms and biomarker-focused diagnostics could shape the next phase of competition.